Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain

Clinical Transplantation

Volumn 20, Issue 5, 2006, Pages 650-658

  González Posada, José Manuel ^a   Hernández, Domingo ^a   Genís, Beatriz Bayés ^b   Tamajón, Lourdes Perez ^a   Pérez, Javier García ^c   Maceira, Benito ^a   Sánchez, Manuel Rivero ^d   Serón, Daniel ^e   Franco, A ^f   Olivares, J ^f   Cubero, J J ^g   Diaz C ^g   Gomez Ullate P ^h   Lampreabe, I ^h   Guirado, L ⁱ   Diz J M ⁱ   Sola R ⁱ   Moreso, F ^j   Grinyo, J M ^j   Esforzado, N ^k   Oppenheimer, F ^k   Lloveras, J ^l   Puig, J M ^l   Bayes B ^b   Lauzurica, R ^b   Cantarell, C ^m   Capdevila, L ^m   Mazuecos, A ^d   Rivero, M ^d   Del Castillo, D ⁿ   Perez Calderon R ⁿ   Asensio, C ^o   Osuna, A ^o   Oliver, J ^p   Alonso, A ^p   Checa, D ^q   Plaza, J J ^r   Fernandez J ^s   Sanz, D ^s   Andres A ^t   Prats, D ^u   Sanchez Fructuoso A ^u   Naranjo, P ^u   Anaya, F ^v   Rengel, M ^v   Jimenez C ^w   Sanz, A ^w   Escuin, F ^w   Alferez M J ^x   Glez Molina, M ^x   Gomez Huertas E ^y   Ortega, F ^y   Errasti, P ^z   Garcia I ^z   Palomar, R ^aa   Fernandez G ^aa   Romero, R ^ab   Sanchez Guisande D ^ab   Rodriguez Algarra G ^ac   Gentil, M A ^ac   Pereira, P ^ac   Gonzalez Posada J M ^ad   Torres, A ^ad   Garcia J ^ae   Rivero, A ^ae   Crespo, F ^af   Beneyto, I ^af   Sanchez Plumed J ^af   Bustamante, J ^ag   Mendiluce, A ^ag   Gutierrez A ^ah   Gutierrez J A ^ah   Paul, J ^ah   more..

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HU   (Spain)

^g HOSPITAL INFANTA CRISTINA   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ FUNDACIÓ PUIGVERT   (Spain)

^j H Bellvitge   (Spain)

^k Servicio de Enfermedades Autoinmunes H Clinic   (Spain)

^l H del Mar   (Spain)

^m H G Vall d'Hebron   (Spain)

ⁿ HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^o HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^p HOSPITAL JUAN CANALEJO   (Spain)

^q H Insular   (Spain)

^r Fundation Jimenez Diaz   (Spain)

^s HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^t HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^u HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^v Hospital Universitario Gergorio Maranon   (Spain)

^w HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^x H R Carlos Haya   (Spain)

^y H G Asturias   (Spain)

^z UNIVERSITY OF NAVARRA   (Spain)

^aa HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^ab Instituto de Salud Carlos III   (Spain)

^ac HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^ad UNIVERSIDAD DE LA LAGUNA   (Spain)

^ae H Virgen del Rocío ^*  (Spain)

^af H Dr Peset   (Spain)

^ag UNIVERSITY OF VALLADOLID   (Spain)

^ah H Miguel Servet   (Spain)

more..

Author keywords

Cardiovascular risk; Kidney transplantation; Patient survival; Post transplant diabetes mellitus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULSE PRESSURE; RECIPIENT; RETROSPECTIVE STUDY; SPAIN; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TRANSPLANTATION, HOMOLOGOUS; TRIGLYCERIDES;

EID: 33748674395     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00532.x     Document Type: Article

References (28)

1. Ojo AO, Hanson JA, Wolfe RA et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307.
2. Foley RN, Parfrey PS, Sarnak MJ. Cardiovascular disease in chronic renal disease. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998: 32 (Suppl. 3): S112.
3. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003: 108: 2154.
4. Boots JM, Christiaans MH, Van Hooff JP. Effect of immunosuppressive agents on long-term survival of transplants recipients: Focus on the cardiovascular risk. Drugs 2004: 64: 2047.
5. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001: 59: 732.
6. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005: 79: 438.
7. Cosio FG, Kudva Y, Van Der Velde M et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk alter kidney transplantation. Kidney Int 2005: 67: 2415.
8. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003: 3: 1.
9. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002: 62: 1440.
10. Revanur KR, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001: 15: 89.
11. Gonzalez-Posada JM, Hernandez D, Bayes Genis B, Garcia Perez J, Rivero Sánchez M. Impact of diabetes mellitus on kidney transplant recipients in Spain. Nephrol Dial Transplant 2004: 19 (Suppl. 4): 57.
12. Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield M. Development of diabetes mellitus following kidney transplantation: A Canadian experience. Am J Transplant 2004: 4: 1876.
13. Seron D, Arias M, Campistol JM, Morales JM. Late renal allograft failure between 1990 and 1998 in Spain: A changing scenario. Transplantation 2003: 76: 1588.
14. University of Waterloo, Carleton University, and Simon Fraser University. Efficient random imputation for missing data in complex surveys. Statistica Sinica 2000: 10: 1153.
15. Bloom RD, Rao V, Weng F, Groossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002: 13: 1374.
16. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk alter renal transplantation. J Am Soc Nephrol 2000: 11: 1735.
17. Armstrong K, Campbell SB, Hawley CM, Nicol DL, Johnson DW, Isbel NM. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 2005: 5: 2710.
18. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005: 28: 1769.
19. Rogers CC, Alloway RR, Buell JF et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation 2005: 80: 26.
20. Kasiske B, Cosio F, Beto J et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Foundation Kidney Disease Outcome Quality Initiative. Am J Transplant 2004: 4 (Suppl. 7): 13.
21. Roodnat JI, Mulder PG, Zietse R et al. Cholesterol as an independent predictor of outcome after renal transplantation. Transplantation 2000: 69: 1704.
22. Executive Summary of the Third Report of the National Cholesterol Educational Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001: 285: 2486.
23. Prasad GVR, Kim SJ, Huang M et al. Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins). Am J Transplant 2004: 4: 1897.
24. Kasiske BL, Anjum S, Shah R et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004: 43: 1071.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997: 20: 1183.
26. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes mellitus after transplantation: 2003 International Consensus Guidelines. Transplantation 2003: 75: SS3.
27. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979: 28: 1039.
28. Shah A, Kendall G, Demme RA et al. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation 2005: 80: 775.